Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
2377–2412
Headlines
3603
Sources here
11
Companies here
25
Current section United States Drug Manufacturers - Specialty & Generic news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Akebia Therapeutics Inc (AKBA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Akebia Therapeutics Inc's (AKBA) stock performance, market capitalization, and dividend history. It highlights that the company has not distributed any dividends over the past five years. The page also offers general financial data and company information for AKBA.

AKBA main company
Sharemaestro market context Price below Trend Line 52 weeks -72.6% AKBA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Liquidia Corp (LQDA) Earnings Forecast: Future EPS & Revenue Growth Estimates

Liquidia Corp (LQDA) has a current earnings forecast score of 8.50, ranking 33rd in the Pharmaceuticals industry. Analysts have an average price target of $47.00 for LQDA, with most recommending a "Buy" trend. The company's expected revenue for the next quarter is $168.54 million, …

LQDA main company
Sharemaestro market context Trend signal active 52 weeks +177.3% · Next-week setup positive 56.2% LQDA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Anika Therapeutics Inc (ANIK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Anika Therapeutics Inc (ANIK) by business segment and geographical region. For the fiscal year 2025, the company's revenue was primarily driven by its OEM Channel and Commercial Channel. The United States contributed the largest portion of …

ANIK main company
Sharemaestro market context Trend signal active 52 weeks +122.8% ANIK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Talphera Inc (TLPH) Cash Flow

This article provides a deep dive into Talphera Inc's (TLPH) cash flow statements, offering both annual and quarterly data to assess its financial health. It details operating, investing, and financing cash flows, along with changes in working capital and free cash flow. The content …

TLPH main company
Sharemaestro market context Trend signal active 52 weeks +149.6% · Next-week setup negative 38.8% TLPH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Talphera Inc (TLPH) Income Statement

This article provides the quarterly and annual income statements for Talphera Inc (TLPH), detailed financial data including revenue, operating expenses, and net income, and a set of frequently asked questions to help users understand how to interpret the financial statements. It shows that Talphera …

TLPH main company
Sharemaestro market context Trend signal active 52 weeks +149.6% · Next-week setup negative 38.8% TLPH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Can Takeda Pharmaceutical (TSE:4502) Trade At A Discount On New Phase 3 Psoriasis Data?

Takeda Pharmaceutical (TSE:4502) has released positive Phase 3 data for its oral TYK2 inhibitor zasocitinib for plaque psoriasis, which has contributed to recent share price momentum. Despite this, the stock trades below analyst price targets and some intrinsic value estimates, suggesting it may be …

TAK main company
Sharemaestro market context Price above Trend Line 52 weeks +16.1% TAK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HUTCHMED (China) Ltd (HCM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of HUTCHMED (China) Ltd (HCM) stock, focusing on its dividend and stock split history. It notes that no dividend data is available for the past five years. The page also includes current stock performance metrics and market capitalization for …

HCM main company
Sharemaestro market context Price below Trend Line 52 weeks -24.2% HCM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Redhill Biopharma Ltd (RDHL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Redhill Biopharma Ltd (RDHL) shareholder structure, listing major shareholders and their proportional holdings, as well as institutional shareholding activities over several quarters. Key shareholders include Yorkville Advisors Global, LP., Gagnon Securities LLC, and Citadel Advisors LLC. The …

RDHL main company
Sharemaestro market context Price below Trend Line 52 weeks -54.2% · Next-week setup negative 35.9% RDHL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zhengye Biotechnology Holding Ltd (ZYBT) Institutional Confidence

This article provides details on the institutional shareholding and shareholder activity for Zhengye Biotechnology Holding Ltd (ZYBT). It lists the top institutional holders and changes in their shares held, showing new or increased positions from several firms like XTX Markets LLC and Winton Capital …

ZYBT main company
Sharemaestro market context Trend signal active 52 weeks -77.7% · Next-week setup negative 43.2% ZYBT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gelteq Ltd (GELS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Gelteq Ltd (GELS), listing both major individual and corporate shareholders, along with a breakdown by shareholder type such as individual investors, corporations, and hedge funds. It also provides institutional shareholding data over several quarters and recent shareholder …

GELS main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% · Next-week setup negative 42.9% GELS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lantheus Holdings Inc (LNTH) Cash Flow

This article provides a detailed cash flow statement for Lantheus Holdings Inc (LNTH), broken down into operating, investing, and financing activities on a quarterly and annual basis. It includes historical data spanning many years, along with year-over-year percentage changes. The piece also features a …

LNTH main company
Sharemaestro market context Trend signal active 52 weeks +73.4% LNTH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aurora Cannabis receives ISS support for AGM resolutions By Investing.com

Aurora Cannabis Inc. announced that Institutional Shareholder Services (ISS) has recommended shareholders vote in favor of all resolutions at the company's upcoming Annual General Meeting (AGM) on August 7, 2026. This support from ISS, an independent proxy advisory firm, validates Aurora's governance framework. Shareholders …

ACB main company
Sharemaestro market context Price above Trend Line 52 weeks -26.3% · Next-week setup negative 41.6% ACB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aurora Cannabis (ACB) Receives Support from Proxy Advisory Firm

Aurora Cannabis (ACB) has received a positive endorsement from Institutional Shareholder Services (ISS), which has advised investors to support all management proposals at the upcoming Annual General Meeting on August 7. Despite challenges in revenue growth and negative earnings, the company holds a moderate …

ACB main company
Sharemaestro market context Price above Trend Line 52 weeks -26.3% · Next-week setup negative 41.6% ACB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cronos Group Inc (CRON) Cash Flow

This article provides a detailed cash flow statement for Cronos Group Inc (CRON), covering annual and quarterly data from FY2014Q1 to FY2026Q1. It breaks down cash flows into operating, investing, and financing activities, along with explanations and key financial metrics like operating cash flow, …

CRON main company
Sharemaestro market context Trend signal active 52 weeks +20.8% CRON stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alvotech SA (ALVO) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Alvotech SA (ALVO), listing both major shareholders and institutional holdings. It shows that Aztiq Pharma Partners SARL and Celtic Holdings SCA are the largest shareholders, alongside other institutional investors. The report also includes historical data on institutional …

ALVO main company
Sharemaestro market context Price above Trend Line 52 weeks -52.0% · Next-week setup negative 43.6% ALVO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Haleon rises Monday, outperforms market

Haleon PLC's shares increased by 1.84% to £3.70 on Monday, outperforming the FTSE 100 Index which rose 0.42%. The company's stock closed 11.03% below its 52-week high of £4.16 reached on February 18th.

HLN main company
Sharemaestro market context Price below Trend Line 52 weeks +0.1% · Next-week setup positive 56.8% HLN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gelteq Ltd (GELS) Balance Sheet

This article provides a detailed balance sheet for Gelteq Ltd (GELS), presenting both quarterly and annual financial data. It allows users to assess the company's financial health by analyzing assets, liabilities, and shareholders' equity, and to calculate key financial ratios. The page also includes …

GELS main company
Sharemaestro market context Price below Trend Line 52 weeks -55.0% · Next-week setup negative 42.9% GELS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Harrow Schedules Aug. 11 Call to Discuss Second-Quarter Results

Harrow (Nasdaq: HROW) will report its second-quarter 2026 financial results after the market close on Monday, August 10, 2026. The company will also host a conference call and live webcast to discuss the results and provide a business update at 8:00 a.m. Eastern Time …

HROW main company
Sharemaestro market context Price above Trend Line 52 weeks +2.3% · Next-week setup positive 56.7% HROW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HUTCHMED (China) Ltd (HCM) Cash Flow

The article provides a detailed cash flow statement for HUTCHMED (China) Ltd (HCM), presenting both annual and quarterly data. It covers operating, investing, and financing cash flows, along with free cash flow, to help evaluate the company's financial health. The data includes year-over-year percentage …

HCM main company
Sharemaestro market context Price below Trend Line 52 weeks -24.2% HCM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amneal Pharmaceuticals, Inc. Class A Revenue Breakdown – FWB:2DT

Amneal Pharmaceuticals, Inc. Class A (FWB:2DT) generated 2.57 billion EUR last year, with its Affordable Medicines segment being the top performer contributing 1.49 billion EUR. The primary revenue sources by region were the United States, India, and Ireland. The company's total revenue saw a …

AMRX main company
Sharemaestro market context Trend signal active 52 weeks +89.3% · Next-week setup positive 58.1% AMRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Supernus Pharmaceuticals Inc (SUPN) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Supernus Pharmaceuticals Inc (SUPN) focusing on its dividend and stock split history. It notes that the company has not distributed dividends totaling 0.00 USD over the past five years and contains no data on past dividend payments or …

SUPN main company
Sharemaestro market context Price below Trend Line 52 weeks +7.6% SUPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Weekly Recap: Guggenheim hikes NBIX price target and Siddhanti named CBO

Guggenheim has reiterated a Buy rating on Neurocrine Biosciences (NBIX) and increased its price target to $200. Additionally, Neurocrine Biosciences has appointed Samir Siddhanti as its new Chief Business Officer, tasked with driving growth, business development, and corporate strategy, aiming to maximize the value …

NBIX main company
Sharemaestro market context Trend signal active 52 weeks +12.8% · Next-week setup positive 56.9% NBIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioAge Labs, Inc. $BIOA Shares Sold by Orbimed Advisors LLC

Orbimed Advisors LLC reduced its stake in BioAge Labs (NASDAQ:BIOA) by 10% in the first quarter, selling 79,090 shares and retaining 711,811 shares valued at approximately $12.45 million. Despite this, other institutional investors like Geode Capital Management, Marshall Wace, and Mirae Asset Global ETFs …

BIOA main company
Sharemaestro market context Price below Trend Line 52 weeks +129.9% · Next-week setup positive 65.7% BIOA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ISS recommends shareholders vote for all Aurora Cannabis resolutions

Institutional Shareholder Services Inc. (ISS) has advised shareholders of Aurora Cannabis Inc. (NASDAQ: ACB) to approve all proposed resolutions at the company's upcoming Annual General Meeting on August 7, 2026. The resolutions include fixing the number of directors, electing directors, appointing an auditor, and …

ACB main company
Sharemaestro market context Price above Trend Line 52 weeks -26.3% · Next-week setup negative 41.6% ACB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Aurora Cannabis (NASDAQ: ACB) wins ISS support for 2026 shareholder vote

Institutional Shareholder Services (ISS) has recommended that Aurora Cannabis shareholders vote FOR all resolutions at its upcoming 2026 Annual General Meeting. The virtual AGM is scheduled for August 7, 2026, with a proxy voting deadline of August 5, 2026. Aurora's CEO, Miguel Martin, welcomed …

ACB main company
Sharemaestro market context Price above Trend Line 52 weeks -26.3% · Next-week setup negative 41.6% ACB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Biofrontera Inc (BFRI) Cash Flow

This article provides a detailed cash flow statement for Biofrontera Inc (BFRI), covering quarterly and annual data for operating, investing, and financing activities. It presents financial figures in millions of USD, along with year-over-year percentage changes, and includes FAQs explaining key cash flow concepts …

BFRI main company
Sharemaestro market context Trend signal active 52 weeks +34.9% · Next-week setup negative 42.9% BFRI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rice Hall James & Associates LLC Acquires Shares of 251,066 Xeris Biopharma Holdings, Inc. $XERS

Rice Hall James & Associates LLC recently acquired 251,066 shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) worth approximately $1.46 million, contributing to institutional and hedge fund ownership of 42.75% of the company. Analysts maintain a "Moderate Buy" rating with a consensus target price of …

XERS main company
Sharemaestro market context Trend signal active 52 weeks +11.0% · Next-week setup positive 55.8% XERS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Regencell Bioscience Holdings Ltd (RGC) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in Regencell Bioscience Holdings Ltd (RGC). It details the institutional shareholding and shareholder activity, listing various firms and their stake changes. The data indicates significant institutional interest and varying portfolio adjustments among these investors.

RGC main company
Sharemaestro market context Price below Trend Line 52 weeks -57.4% · Next-week setup negative 33.9% RGC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 7.17% Potential Upside in the Healthcare Sector

Lantheus Holdings Inc. (LNTH), a healthcare company specializing in diagnostic and therapeutic products, shows a potential upside of 7.17% according to analyst ratings. The company maintains a market capitalization of $6.82 billion, a forward P/E of 16.64, and strong financial health with $421.7 million …

LNTH main company
Sharemaestro market context Trend signal active 52 weeks +73.4% LNTH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Curium in Talks to Acquire Lantheus For $7 Billion

Curium is reportedly in discussions to acquire Lantheus Holdings, Inc. for $7 billion. This potential acquisition follows recent news of Lantheus weighing a sale after Curium's initial offer. Lantheus specializes in radiopharmaceuticals for diagnostics and treatment in areas like oncology, neurology, and cardiology.

LNTH main company
Sharemaestro market context Trend signal active 52 weeks +73.4% LNTH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Amphastar Pharmaceuticals Inc (AMPH), listing major shareholders such as Applied Physics & Chemistry Laboratories, Inc., BlackRock Institutional Trust Company, N.A., and key individual investors. It also provides a breakdown of shareholder types, institutional holdings over several quarters, …

AMPH main company
Sharemaestro market context Price below Trend Line 52 weeks -31.4% AMPH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rice Hall James & Associates LLC Increases Position in Amphastar Pharmaceuticals, Inc. $AMPH

Rice Hall James & Associates LLC increased its stake in Amphastar Pharmaceuticals (NASDAQ:AMPH) by 54.6% in the first quarter, now holding 187,348 shares valued at $3.67 million. Despite institutional ownership accounting for 65.09% of the company, Amphastar Pharmaceuticals missed first-quarter earnings and revenue estimates …

AMPH mentioned
Sharemaestro market context Price below Trend Line 52 weeks -31.4% AMPH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Octagon Capital Advisors LP Has $30.57 Million Stock Position in BioAge Labs, Inc. $BIOA

Octagon Capital Advisors LP has increased its holdings in BioAge Labs, Inc. by 9.4%, now owning 1.748 million shares valued at $30.57 million. BioAge Labs, a clinical-stage biotechnology company, reported a smaller-than-expected quarterly loss of $0.52 per share on $2.77 million in revenue, though …

BIOA main company
Sharemaestro market context Price below Trend Line 52 weeks +129.9% · Next-week setup positive 65.7% BIOA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Regencell Bioscience Holdings Ltd (RGC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Regencell Bioscience Holdings Ltd (RGC), detailing various technical indicators and moving averages to assess its current stock performance. It includes a summary of buy, sell, and neutral signals from indicators like MACD, RSI, and STOCH, as well …

RGC main company
Sharemaestro market context Price below Trend Line 52 weeks -57.4% · Next-week setup negative 33.9% RGC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TRLV|Trulieve Cannabis Subordinate Voting Ord Shs|Price:9.650|Chg%:+0.035

This article provides a detailed profile of Trulieve Cannabis Corp. (TRLV), a vertically integrated cannabis company. It covers the company's background, business scope, financial data, and market performance, highlighting its operations in three regional hubs and its various cannabis brands. The profile also lists …

TRLV main company
Sharemaestro market context Stored weekly price path 10 weeks -6.8% TRLV stored weekly price path from 12 Jun 2026 to 14 Aug 2026

Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Lifecore Biomedical Inc (LFCR)'s dividend and stock split history. It states that the company has distributed $0.00 in dividends over the past 5 years, indicating no recent dividend payouts. The page also presents current stock data for LFCR.

LFCR main company
Sharemaestro market context Price below Trend Line 52 weeks -37.9% LFCR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context